StockSignal
The Patient Investor

The Patient Investor

View channel →

The Patient Investor has made 19 tracked stock calls (16 buy). 44,000 subscribers.

Get alerts for The Patient Investor

New recommendations delivered by email or Telegram. We'll ask you to confirm before sending anything.

Recommendation history

The Patient Investor on this stock

High conviction long term investment backed by multi-asset diversification, growing high margin recurring revenue streams, and leadership in tokenization.

The Patient Investor on this stock

Attractive long term opportunity supported by accelerating growth, skilled leadership executing cheap acquisitions, and favorable consumer trends toward eating at home.

The Patient Investor on this stock

Preferring a luxury sector turnaround candidate with proven pricing power and steady earnings growth over vulnerable discretionary retailers.

The Patient Investor on this stock
The Patient Investor The Patient Investor QCOM Buy/Bought

Highlighting depressed sentiment, expanding automotive and edge computing opportunities, and significant projected upside, backed by major industry partnerships and recent personal investment.

The Patient Investor on this stock

Exceedingly expensive valuation relative to growth and industry peers makes the stock unjustified at current levels.

The Patient Investor on this stock

Superior leadership and explosive growth combined with a vastly more attractive earnings multiple.

The Patient Investor on this stock

Highly compelling setup backed by a very low earnings multiple relative to future guidance.

The Patient Investor on this stock

Undervalued waste management business offering asymmetrical upside from potential private equity acquisition and robust recession-resistant cash flow growth.

The Patient Investor on this stock

Misunderstood semiconductor stock transitioning away from cyclical handsets into rapidly growing automotive and custom silicon markets with substantial potential upside.

The Patient Investor on this stock

Valuation has become attractive with significant long-term upside potential relative to forward earnings growth.

The Patient Investor on this stock

Identifying an attractive valuation and massive potential monetization through agentic experiences on WhatsApp.

The Patient Investor on this stock

Spotting an exceptional risk-to-reward setup with the stock trading at an attractive forward earnings multiple.

The Patient Investor on this stock

Rejecting the idea of selling an appreciating position given reasonable earnings multiples and accelerating cloud growth.

The Patient Investor on this stock

Planning further portfolio accumulation during market pullbacks for the largest holding backed by strong operating cash flow growth.

The Patient Investor on this stock
The Patient Investor The Patient Investor QCOM Buy/Bought

Valued at an attractive price multiple with significant long-term growth potential driven by diversification into automotive, IoT, and data center markets.

The Patient Investor on this stock

Undervalued status supported by a low multiple of 12 times free cash flow despite strong growth.

The Patient Investor on this stock

Offering an attractive long-term investment opportunity for positioning in industrial automation and robotics sensors.